PubMed

CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection.

Angel JB, Cooper CL, Clinch J, Young CD, Chenier A, Parato KG, Lautru M, Davis H, Cameron DW.

J Immune Based Ther Vaccines. 2008 Aug 12;6:4.PMID: 18700037 [PubMed - in process]Free PMC ArticleFree textRelated citations

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

Cooper CL, Davis HL, Angel JB, Morris ML, Elfer SM, Seguin I, Krieg AM, Cameron DW.

AIDS. 2005 Sep 23;19(14):1473-9.PMID: 16135900 [PubMed - indexed for MEDLINE]Related citations

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.

Cooper CL, Angel JB, Seguin I, Davis HL, Cameron DW.

Clin Infect Dis. 2008 Apr 15;46(8):1310-4.PMID: 18444872 [PubMed - indexed for MEDLINE]Related citations

[CpG oligodeoxynucleotide enhances humoral and cellular immune responses against HBsAg in mice]

Zhou Z, Chen WS, Yao JL.

Zhonghua Nei Ke Za Zhi. 2003 Sep;42(9):640-2. Chinese. PMID: 14514394 [PubMed - indexed for MEDLINE]Related citations

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.

Vaccine. 2008 Mar 4;26(10):1375-86. Epub 2008 Jan 14.PMID: 18272264 [PubMed - indexed for MEDLINE]Related citations

Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

Mutwiri G, Benjamin P, Soita H, Babiuk LA.

Vaccine. 2008 May 23;26(22):2680-8. Epub 2008 Apr 3.PMID: 18430493 [PubMed - indexed for MEDLINE]Related citations

A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases.

Gupta K, Cooper C.

Drugs R D. 2008;9(3):137-45. Review.PMID: 18457466 [PubMed - indexed for MEDLINE]Related citations

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.

Makidon PE, Bielinska AU, Nigavekar SS, Janczak KW, Knowlton J, Scott AJ, Mank N, Cao Z, Rathinavelu S, Beer MR, Wilkinson JE, Blanco LP, Landers JJ, Baker JR Jr.

PLoS One. 2008 Aug 13;3(8):e2954.PMID: 18698426 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system.

Jain V, Sahu R, Misra-Bhattacharya S, Vyas SP, Kohli D.

J Drug Target. 2008 Nov;16(9):706-15.PMID: 18982519 [PubMed - indexed for MEDLINE]Related citations

Enhancement of immune responses to hepatitis B vaccine in immunodepressed mice by CpG oligodeoxynucleotide.

Qin WB, Jiang JW, Yang N, Chen QE, Wang YF, Wei XC, Ou RQ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 Nov;20(6):647-50.PMID: 15555425 [PubMed - indexed for MEDLINE]Related citations

Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.

Xie Y, Sun HX, Li D.

Vaccine. 2009 Jan 29;27(5):757-64. Epub 2008 Nov 27.PMID: 19041358 [PubMed - indexed for MEDLINE]Related citations

DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.

Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D.

Vaccine. 2006 Feb 13;24(7):970-9. Epub 2005 Sep 6.PMID: 16242220 [PubMed - indexed for MEDLINE]Related citations

Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

Herasimtschuk AA, Westrop SJ, Moyle GJ, Downey JS, Imami N.

J Immune Based Ther Vaccines. 2008 Oct 31;6:7.PMID: 18976455 [PubMed - in process]Free PMC ArticleFree textRelated citations

Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.

Cote PJ, Butler SD, George AL, Fairman J, Gerin JL, Tennant BC, Menne S.

J Med Virol. 2009 Oct;81(10):1760-72.PMID: 19697409 [PubMed - indexed for MEDLINE]Related citations

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.

Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.

Eur J Pharm Sci. 2007 Dec;32(4-5):278-90. Epub 2007 Aug 15.PMID: 17884394 [PubMed - indexed for MEDLINE]Related citations

Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation.

Iglesias E, García D, Carrazana Y, Aguilar JC, Sánchez A, Gorobaya L, Blanco A.

Curr HIV Res. 2008 Sep;6(5):452-60.PMID: 18855656 [PubMed - indexed for MEDLINE]Related citations

Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.

Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.

Antivir Ther. 2009;14(1):131-5.PMID: 19320247 [PubMed - indexed for MEDLINE]Related citations

Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers.

Sleijffers A, Garssen J, de Gruijl FR, Boland GJ, van Hattum J, van Vloten WA, van Loveren H.

J Invest Dermatol. 2001 Nov;117(5):1144-50.PMID: 11710925 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.

Cheng C, Bettahi I, Cruz-Fisher MI, Pal S, Jain P, Jia Z, Holmgren J, Harandi AM, de la Maza LM.

Vaccine. 2009 Oct 19;27(44):6239-46. Epub 2009 Aug 15.PMID: 19686693 [PubMed - indexed for MEDLINE]Related citations

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.

Eur J Pharm Biopharm. 2008 Jun;69(2):405-16. Epub 2008 Jan 31.PMID: 18364251 [PubMed - indexed for MEDLINE]Related citations